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This study examined whether the antidermatophytic activity of essential oils (EOs) can be used as an indicator for 
the discovery of active natural products against Leishmania amazonensis. The aerial parts of seven plants were hydro-
distilled. Using broth microdilution techniques, the obtained EOs were tested against three strains of dermatophytes 
(Trichophyton mentagrophytes, Microsporum gypseum and Microsporum canis). To compare the EOs antifungal and 
antiparasitic effects, the EOs activities against axenic amastigotes of L. amazonensis were concurrently evaluated. For 
the most promising EOs, their antileishmanial activities against parasites infecting peritoneal macrophages of BALB/c 
mice were measured. The most interesting antifungal candidates were the EOs from Cymbopogon citratus, Otacanthus 
azureus and Protium heptaphyllum, whereas O. azureus, Piper hispidum and P. heptaphyllum EOs exhibited the lowest 
50% inhibitory concentration (IC50) values against axenic amastigotes, thus revealing a certain correspondence be-
tween both activities. The P. hispidum EO was identified as the most promising product in the results from the infected 
macrophages model (IC50: 4.7 µg/mL, safety index: 8). The most abundant compounds found in this EO were sesquiter-
penes, notably curzerene and furanodiene. Eventually, the evaluation of the antidermatophytic activity of EOs appears 
to be an efficient method for identifying new potential drugs for the treatment of L. amazonensis.
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A promising, current strategy for the discovery of 
bioactive natural products is based on bioinspiration. 
The aim is to understand the functional role of second-
ary metabolites in living organisms and transpose the 
desirable properties to a corresponding research field. 
Gaining inspiration from the abilities of plants or mi-
croorganisms to produce adapted bioactive molecules 
under environmental pressure has led to some promis-
ing results, for example, in the search for antibiotic or 
antiviral agents (Pan et al. 2010) or natural antifungal 
products (Basset et al. 2012). Essential oils (EOs) are 
composed of volatile odoriferous compounds which 
play a major role in the complex interactions taking 
place between plants and pollinators, herbivorous in-
sects, larger herbivores or microorganisms. In partic-
ular, they are among the most efficient antimicrobial 
compounds of plants’ chemical defense systems (Un-
sicker et al. 2009). This antimicrobial activity points 
to the use of a bioinspired strategy for the search for 
antifungal compounds within EOs. In the context of the 
growing interest in the uses of medicinal plants and, 
especially, EOs as new antifungal agents (Rios & Recio 
2005), we examined seven EOs obtained from particu-
larly fragrant plant species from French Guiana, pre-
saging a distinctive richness and complexity of volatile 
compounds that potentially exhibit antimicrobial activ-
ity. In addition, the extensive search for new drugs to 
treat leishmaniasis is definitely necessary because the 
limited number of currently available products pres-
ent noticeable side effects and the resistance to these 
products is increasing (Rocha et al. 2005). Known an-
tifungal drugs such as amphotericin B, miltefosine and 
azoles have also demonstrated activity against Leish-
mania parasites (Moskowitz & Kurban 1999, Tong et 
al. 2007, Shakya et al. 2011b). These successful results 
led to the development of the “therapeutic switching” 
or “alternative drug use” strategy (Shakya et al. 2011a). 
In accord with this perspective, we evaluated the an-
tileishmanial properties of selected antidermatophytic 
EOs. To our knowledge, the correspondence between 
these two activities has never been investigated for 
these particular natural products.
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MATERIALS AND METHODS
General remarks - Plant material and sample prepa-
ration - Seven EOs were obtained: Achetaria guianen-
sis Pennell (Scrophulariaceae, leaves and stems), Cym-
bopogon citratus (DC.) Stapf (Poaceae, leaves), Mikania 
micrantha Kunth (Asteraceae, aerial parts), Otacanthus 
azureus (Linden) Ronse (Plantaginaceae, aerial parts), 
Piper hispidum Sw. (Piperaceae, leaves), Protium hep-
taphyllum (Aubl.) Marchand (Burseraceae, fresh green 
fruits), Vouacapoua americana Aubl. (Fabaceae, wood). 
Herbarium vouchers (respectively Silland 8, 40, 31, 30, 
23, 20 and Rodrigues 6) were deposited in the French 
Guiana herbarium (CAY), where specialists (S Gonzalez, 
MF Prevost, F Crozier) and members of our laboratory 
(E Houël, A Rodrigues) confirmed identification. Plants 
were collected in French Guiana near Regina, Matoury 
and Cayenne, mainly during the rainy season (April-July) 
except for A. guianensis which was collected during the 
dry season (November). The fresh parts collected from 
each plant were hydrodistilled and the EOs were stored 
at -18ºC until the subsequent analyses were performed. 
The material under study is endotoxin free.
Nuclear magnetic resonance (NMR) spectroscopy 
- The 1H NMR spectra and 13C NMR spectra were re-
corded at 400 MHz and 100.6 MHz, respectively, using a 
Varian 400 MR spectrometer equipped with a 5 mm in-
verse probe (Auto X PGF 1H/15N-13C). The EOs were dis-
solved in deuterated chloroform (CDCl3) in 5 mm tubes.
Gas chromatography-mass spectrometry (GC-MS) 
analysis - A Varian 450-GC fitted with a MS240 ion-
trap MS and a Combipal autosampler was used for the 
GC-MS analysis. The GC was run with a non-polar Var-
ian FactorFour VF-5ms column (30 m × 0.25 mm ID, 
0.25 μm film) commonly used for the analysis of VOCs. 
The injection volume (EO dissolved in chromatography-
grade hexane) was 1 µL. Helium was used as the carrier 
gas at a constant flow of 1 mL/min. The column tem-
perature increased from 50-150ºC at 4ºC/min, then from 
150-175ºC at 1.5ºC/min and from 175-300ºC at 20ºC/
min for a total analysis time of 58.42 min. The injec-
tor temperature was set to 250°C and the injection was 
made with a split ratio of 1/50 during the whole run. The 
MS was operated in the electron impact mode at 70 eV, 
with a scan range of 40-400 m/z. The temperatures were 
set to 200ºC for the ion trap, 50ºC for the manifold and 
305ºC for the transfer line. The relative proportions of 
constituents of the EOs were expressed as the percent-
ages obtained by peak area normalisation.
Component identification - The identification of the 
components of the EOs was based on the following: (i) 
GC retention indices (RI) on a non-polar column, (ii) 
computer matching with commercial mass spectral li-
braries (NIST 98 MS, ADAMS) (Adams 2007), (iii) 
comparisons of RI and spectra with those from previous 
work (Courtois et al. 2009, Houël et al. 2014) and from an 
in-house library of analyses of commercial EOs of known 
composition (Aromazone) and (iv) NMR spectroscopy.
Fungal strains - One clinical isolate of a Trichophy-
ton species (Trichophyton mentagrophytes LMGO 1931) 
and two clinical isolates of Microsporum species (Mi-
crosporum gypseum LMGO 10 and Microsporum canis 
LMGO 22) were kindly provided by Dr Maria do Ro-
sario Silva (University Hospital, Federal University of 
Goiás, Brazil). The cultures were maintained on potato 
dextrose agar and were cultured onto a new agar plate at 
28ºC for five days prior to antimicrobial tests.
Parasites and cultures - A cloned line of Leishmania 
amazonensis (strain MHOM/BR/76/LTB-012) was used 
in all of the experiments. An axenically grown amastig-
ote form of L. amazonensis was maintained by weekly 
subculturing in MAA20 medium at 32º+/-1ºC in 25 cm2 
tissue culture flasks with 5% CO2 and supplemented 
with 20% heat-inactivated foetal bovine serum (FBS), 
as previously described (Estevez et al. 2007).
Minimal inhibitory concentration (MIC) - The stan-
dard microdilution test was used to determine the MIC 
of the EOs. The experimental details were similar to 
those described previously (Houël et al. 2014). All as-
says were conducted in triplicate.
Cytotoxicity assay using VERO cells - VERO cells 
(African Green Monkey kidney epithelial cells) were 
seeded (5 x 105 cells mL-1, 100 µL per well) in 96-well 
flat-bottom plates at 37ºC with 5% CO2. RPMI-1640 
medium without phenol red and supplemented with 
10% heat-inactivated FBS was used. After the EOs were 
added, the cells were cultured for 48 h. The effects of 
the treatments were determined using the 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
viability assay. Four hours after the addition of MTT, 
100 µL of lysis buffer [50% isopropanol, 10% sodium 
dodecyl sulfate (SDS)] was added and the cells were 
shaken for 30 min at room temperature (RT). The optical 
density (OD) was read at 595 nm using a 96-well plate 
reader (Chameleon, Hidex; Finland). All experiments 
were performed in triplicate. The median toxic dose 
(TD50) values were determined using linear regression 
analysis. The TD50 was defined as the concentration of 
the test sample that resulted in a 50% reduction of absor-
bance compared to controls.
Activity on axenic amastigotes - All experiments 
were performed in triplicate. The in vitro leishmanicidal 
activities of the EOs were determined in axenic cultures 
of the amastigote form of L. amazonensis. To estimate 
the 50% inhibitory concentration (IC50) of the extracts, 
the MTT was used as previously described (Estevez et al. 
2007). Results were expressed as the percentage reduc-
tion of parasite burden compared to the level in untreat-
ed control wells and the IC50 was determined from the 
concentration response curves (Excel software). Briefly, 
axenically grown amastigotes during the late log phase 
of growth were seeded in 96-well flat bottom microtitre 
plates. EOs, dissolved in dimethyl sulfoxide (DMSO), 
were added at final concentrations ranging from 100-
10 µg/mL. The final DMSO concentration was never > 
0.1%. After 72 h of incubation, 10 µL of MTT (10-3 µg/
mL) was added to each well and the plates were further 
incubated for 4 h. After these 4 h, the enzymatic reac-
tion was stopped with 100 µL of a 50% isopropanol and 
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10% SDS solution and the plates were incubated for an 
additional 30 min under agitation at RT. Finally, the OD 
was read at 595 nm with a 96-well scanner (Bio-Rad). 
The reference compound was amphotericin B.
Activity on Leishmania infected macrophages - 
Mouse peritoneal macrophages were collected in cold 
phosphate buffered saline (pH 7.2). One million mac-
rophages collected from BALB/c mouse were allowed 
to adhere to 12 mm diameter glass coverslips (105 cells 
per coverslip). Coverslips were transferred into 16 mm 
diameter well of 24-well plates. Each well contained 0.5 
mL of RPMI-10% foetal calf serum (FCS) supplemented 
with 100 µg/mL streptomycin and 100 UI/mL penicil-
lin. The adherent cells were cultured at 37ºC under 5% 
CO2 for 3 h. Then the plates were washed with RPMI 
supplemented with hepes, without FCS to eliminate non-
adherent cells. The supernatant was replaced by 0.5 mL/
well of fresh medium RPMI + 10% FCS + antibiotics 
before infection by L. amazonensis amastigotes at a ratio 
of five infecting organisms to one host cell. After a 2 h 
contact, the drugs to be tested were added to the culture 
and maintained at 37ºC under 5% CO2 for 48 h. Then, 
plates were fixed with methanol and stained with 10% 
Giemsa’s stain (Merck). They were fixed up with Gurr 
Resin (BDH Chemicals Ltd, England). Macrophages 
with and without parasites were counted under 40X mag-
nification. For each triplicate assay, the survival index of 
amastigotes was calculated relative to the control.
Ethics - Mice were treated according to French legis-
lation (Ethical Committee, US006 CREFFE, registered 
CEEA-122).
RESULTS
In vitro antifungal activity of EOs - The in vitro anti-
fungal activities of the seven EOs are presented in Table 
I. To improve the clarity of the results, a score represent-
ing the global antifungal activity was attributed to each 
EO. A MIC greater than 500 µg/mL received a 0, a MIC 
of 500 µg/mL received a 1, a MIC of 250 µg/mL received 
a 2 and each subsequent reduction in MIC by a factor of 
2 increased the number of the score by 1. According to 
these scores, the most active antifungal EOs are those 
of C. citratus, with a score of 17 (representing MICs of 
16, 8 and 62 µg/mL against M. gypseum, T. mentagro-
phytes and M. canis, respectively), O. azureus (16) and 
P. heptaphyllum (13). The EOs of V. americana (9) and 
P. hispidum (8) also exhibited high antifungal activity 
with MICs in the 62-500 µg/mL range. The EOs of M. 
micrantha (5) and A. guianensis (0) exhibited weak to 
non-existent activity against the selected dermatophytic 
filamentous fungi (MIC values from 125 to > 500 µg/
mL). Among the remarkably active oils, the MICs re-
corded for the effects of the C. citratus and O. azureus 
EOs were as low as 8 µg/mL against T. mentagrophytes 
and 16 µg/mL against M. gypseum. These values were 
the same as that of the reference antifungal agent flucon-
azole against T. mentagrophytes and only twice that ob-
tained for fluconazole against M. gypseum; both values 
were 8 µg/mL for fluconazole.
Effects of EOs activities on the growth of axenic 
amastigotes and cytotoxic effects on BALB/c mice peri-
toneal macrophages - The seven EOs were concurrently 
tested against axenic amastigotes of L. amazonensis. The 
TABLE I
Minimum inhibitory concentrations (µg/mL), antileishmanial activity against axenic amastigotes [50% inhibitory  
concentration (IC50) (µg/mL)] and cytotoxicity [median toxic dose (TD50) (µg/mL), BALB/c mice peritoneal  
macrophages and VERO cells measured for the selected essential oils (EOs) and the reference antifungal  
(itraconazole and fluconazole) and antileishmanial (amphotericin B) drugs
EO
Dermatophytic filamentous fungi
Leishmania 
amazonensis Cytotoxicity
SIa
Microsporum 
gypseum 
LMGO 10
Trichophyton  
mentagrophytes 
LMGO 1931
Microsporum 
canis 
LMGO 22
Antifungal 
activity 
(score)
IC50 axenic
 amastigotes
TD50 BALB/c 
mice peritoneal  
macrophages
TD50 
VERO 
cells
Achetaria guianensis > 500 > 500 > 500 0 6.3 32.5 30.7 5
Cymbopogon citratus 16 8 62 17 5.3 25.2 10.7 5
Mikania micrantha 250 125 > 500 5 6.8 50.8 93.2 7
Otacanthus azureus 16 8 125 16 0.7 35.5 > 100 51
Piper hispidum 125 62 500 8 3.4 35.5 > 100 11
Protium heptaphyllum 62 31 62 13 3.7 71.2 > 100 19
Vouacapoua americana 62 62 500 9 7.2 34.3 34.5 5
Itraconazole 0.5 0.5 4 - NT NT > 10 NT
Fluconazole 8 8 NT - NT NT 283.2 NT
Amphotericin B NT NT NT - 0.3 3.7 1 12
a: antileishmanial selectivity index (SI) defined as SI = TD50 (BALB/c mice peritoneal macrophages)/IC50 (L. amazonensis axenic 
amastigotes); NT: not tested.
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results are presented in Table I. While the EOs from C. 
citratus, O. azureus and P. heptaphyllum were the most 
interesting antifungal candidates, the EOs of O. azureus, 
P. hispidum and P. heptaphyllum exhibited the lowest IC50 
against axenic amastigotes, thus revealing a certain level 
of correspondence between both activities. A very high 
in vitro activity (IC50 of 0.7 µg/mL) was measured for the 
O. azureus EO. This value is in the same range as the one 
obtained for the reference compound amphotericin B (0.3 
µg/mL). The P. heptaphyllum and P. hispidum EOs were 
also remarkably active against the parasite (IC50 values of 
3.7 and 3.4 µg/mL, respectively). Overall, IC50 values < 
10 µg/mL were recorded for all seven EOs.
We also evaluated the selectivity index (SI) based on 
the toxicity measured on healthy macrophages. The most 
interesting oil in this respect was O. azureus, which had an 
SI value of 51. Among the other oils identified as the most 
active against L. amazonensis, the EOs of P. heptaphyl-
lum and P. hispidum exhibited reasonably high selectivity 
indices of 19 and 11, respectively, which were comparable 
to the value of 12 obtained for amphotericin B. In con-
trast, even though the C. citratus EO was identified as the 
most potent antidermatophytic product and also exhibited 
high antileishmanial activity, this EO was shown to have 
a low SI of only 5 and thus is not as good of a candidate as 
the other three EOs with relatively high SIs.
Based on these results, the EOs of O. azureus, P. hep-
taphyllum and P. hispidum were selected to be further 
evaluated for their antileishmanial activity against para-
sites infecting BALB/c mice peritoneal macrophages.
Cytotoxicity assay on VERO cells - The toxicities 
of the EOs towards VERO cells are presented in Table 
I. Interestingly, the three most antileishmanial EOs (O. 
azureus, P. heptaphyllum and P. hispidum) exhibited no 
cytotoxicity against VERO cells (TD50 > 100 µg/mL). 
The M. micrantha EO was also not cytotoxic. However, 
the EOs of C. citratus, A. guianensis and V. americana 
were all cytotoxic towards VERO cells at concentrations 
between 10-35 µg/mL. These results confirmed the se-
lection of O. azureus, P. heptaphyllum and P. hispidum 
for further evaluation.
Leishmanicidal activity in L. amazonensis-infected 
BALB/c mice peritoneal macrophages - To evaluate 
the potential of the three selected EOs as clinical anti-
leishmanial agents, they were added to a culture media 
containing L. amazonensis-infected BALB/c mice peri-
toneal macrophages (Table II). Notably, the P. hispidum 
EO exerted the highest leishmanicidal effect, with an 
IC50 of 4.7 µg/mL. While this value is superior to the 
one recorded for amphotericin B (0.6 µg/mL), the safety 
indices are very similar.
The infection reduction indices were also calculated. 
In this respect, the P. hispidum EO was the most active 
causing a 97.5% reduction of the infection at a dose of 
20 µg/mL. The same activity was obtained at 2 µg/mL 
for amphotericin B.
Determination of the composition of the P. hispidum 
EO by GC-MS and NMR analyses - As the P. hispidum 
EO was identified as the most promising product in the 
infected macrophages model it was submitted to detailed 
chemical analysis. There were 64 compounds identified 
in the P. hispidum EO, accounting for 90.5% of the com-
position of the oil. The details of the identifications and 
relative concentrations of the compounds found in the 
hydrodistilled oil of P. hispidum are reported in Supple-
mentary Table. The compounds representing more than 
1% of the EO are described in Table III. The chemical 
composition of the P. hispidum EO obtained in this 
study revealed that sesquiterpenes are the most abundant 
compounds; the five most abundant compounds identi-
fied by the GC/MS analysis were curzerene (15.7%), 
germacrene B (10.9%), α and β-selinene (10.5 and 7.6%, 
respectively) and β-caryophyllene (4.7%) (Figure). It is 
known that curzerene can be produced from furanodiene 
through a thermal Cope rearrangement, with 1,4-dienes 
being involved in this [3.3]-sigmatropic reaction due to 
the high temperatures that occur during the injection of 
the sample into the GS (Baldovini et al. 2001). The com-
parison of the 13C NMR spectra of the crude oil with 
the data in the literature allowed us to confirm the pres-
ence of curzerene, but also revealed the presence of the 
heat-sensitive compound furanodiene in the crude EO, 
TABLE II
Antileishmanial activity [50% inhibitory concentration (IC50) (µg/mL)] against infected BALB/c mice peritoneal macrophages, 
safety index for BALB/c mice peritoneal macrophages and infection reduction index at the maximum concentration measured for 
the three most promising essential oils (EOs) and the reference antileishmanial drug (amphotericin B)
EO
Leishmania amazonensis
Safety index 
on macrophages
Infection reduction index (%) 
(maximum concentration, µg/mL)
IC50 BALB/c mice infected
peritoneal macrophages
Otacanthus azureus 16.1 2 64.7 (20)
Piper hispidum 4.7 8 97.5 (20)
Protium heptaphyllum 34.9 2 59.6 (40)
Amphotericin B 0.6 6 (2)
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even if the relative proportions could not be evaluated 
(Baldovini et al. 2001). Hence, the curzerene identified 
in the GC/MS analysis in fact originates from curzerene 
already present in the EO and from its precursor, fura-
nodiene; thus, the quantitative data are affected by the 
contribution from the Cope rearrangement.
DISCUSSION
The three most active antifungal EOs were those from 
C. citratus, O. azureus and P. heptaphyllum. The EO of C. 
citratus has largely been described as antifungal (Shin & 
Lim 2004, da Silva et al. 2008). In our study, the C. citra-
tus EO was mainly composed of neral (31%) and geranial 
(56%), corroborating the already well-known antifungal 
activity of citral, known to act by forming a charge trans-
fer complex with an electron donor of fungal cells and thus 
causing fungal death (da Silva et al. 2008). The antider-
matophytic activity and chemical composition of the O. 
azureus EO has been further studied elsewhere (Houël et 
al. 2014). It was shown to be largely composed of sesquit-
erpenes, with the main component being β-copaen-4-α-ol 
(23%), alongside α-humulene (10.6%), α-copaene (8.8%), 
myrtenal (5.6%), viridiflorol (5.1%) and trans-pinocarveol 
(4.3%). Concerning the EO of P. heptaphyllum, we have 
demonstrated for the first time that the oil extracted from 
fresh green fruits is a highly potent antifungal agent 
against dermatophytic filamentous fungi. Moreover, this 
oil exhibited no cytotoxicity against VERO cells (TD50 > 
100 µg/mL). Further studies should be conducted on this 
EO to confirm the fact that it represents a promising prod-
TABLE III
Main components (> 1 %) of the Piper hispidum essential oil identified by the gas chromatography-mass spectrometry analysis
RIa
Composition
(%) Compound
Courtois et al. 
(2009)
RI 
Adams 
(2007)
Houël et al. 
(2014)
935 1 α-pinene 940 932 936
980 1.4 β-pinene 985 974 981
1379 1.2 α-copaene 1381 1374 1380
1391 2.6 β-elemene 1385 1389 1391
1423 4.7 β-caryophyllene 1427 1417 1424
1432 1.5 γ-elemene 1432 1434 -
1434 1.2 β-copaene - 1430 -
1460 2.2 α-humulene 1462 1452 1461
1476 1.1 selina-4,11-diene 1482 - -
1493 7.7 β-selinene 1496 1489 -
1497 15.7 curzereneb - 1499 -
1499 10.5 α-selinene 1496 1498 1499
1515 1.1 γ-cadinene 1518 1513 -
1519 3.4 δ-cadinene 1521 1522 -
1524 1.4 calamenene (UI) - 1521/1528 1524
1561 10.9 germacrene B 1567 1559 -
1597 1.4 viridiflorol - 1592 1599
1620 1.3 1,10-di-epi-cubenol - 1613c -
1657 3.9 7-epi-a-eudesmol - 1662 -
1660 4.6 junicedranone - 1664 -
Total 78.9 - - - -
a: the identified constituents are listed in their order of elution from a non-polar column (Varian FactorFour VF-5ms); b: 
from curzerene and furanodiene. Quantitative data are affected by thermal rearrangement; c: Cicció and Chaverri (2008); RI: 
retention indices; UI: undetermined isomer.
Main components of the Piper hispidum essential oil identified by gas 
chromatography-mass spectrometry.
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uct for the treatment of human superficial dermatomyco-
ses. In our extract, the P. heptaphyllum EO was mainly 
composed of limonene (82%), along with small propor-
tions of other monoterpenes (α-pinene 5.4%, β-pinene 
2.5%, p-cymene 1.5%, trans-carveol 0.9%, β-myrcene 
0.7% and carvone 0.7%). This composition differs from 
the one already published for immature fruits (Pontes et 
al. 2007), which indicated that the primary component 
was α-terpinene. We tested the three main compounds 
for their antidermatophytic activities, but all of them 
were inactive. Similarly to the O. azureus EO, the anti-
fungal activity could thus be due to a synergistic effect 
of multiple compounds, as that described for limonene 
and α-pinene on S. cerevisiae or to the activity of a minor 
component (Tserennadmid et al. 2011). In addition, the 
EOs of V. americana and P. hispidum also exhibited sig-
nificant antifungal activity. Antidermatophytic as well as 
antimicrobial activity have already been described in the 
literature for some P. hispidum EOs (Morales et al. 2013, 
Tangarife-Castaño et al. 2014).
The seven oils were concurrently tested against ax-
enic amastigotes of L. amazonensis. Infections with this 
parasite result in a clinical spectrum of manifestations 
that includes all three forms of leishmaniasis (cutane-
ous, mucosal and visceral) (Rocha et al. 2005). Of the 
three most antifungal EOs, two of them (O. azureus and 
P. heptaphyllum) also exhibited remarkable antileish- 
manial activities, especially O. azureus (IC50 0.7 µg/mL). 
Concerning O. azureus EO, none of its main components 
has to our knowledge been clearly identified as antileish-
manial. However, P. heptaphyllum EO was shown to be 
mainly composed of limonene, recently demonstrated to 
attack the plasma membrane of the parasite (Camargos 
et al. 2014). A third oil, that of P. hispidum leaves, was 
also identified as a potent antiamastigote agent with an 
IC50 of 3.4 µg/mL. We had previously observed that this 
EO exhibited significant antifungal activity, demonstrat-
ed by a high score for activity (8) and MIC values rang-
ing from 62-500 µg/mL. Notably, the C. citratus EO was 
identified as the most potent antidermatophytic product 
and also demonstrated significant anti-amastigote ac-
tivity. This dual activity against both filamentous der-
matophytic fungi and Leishmania sp. amastigotes has 
already been observed with miltefosine, amphotericin B 
and azoles (Moskowitz & Kurban 1999, Tong et al. 2007, 
Shakya et al. 2011b). In fact, amphotericin B and azoles, 
which were initially developed as antifungals and are now 
used (or have been successfully tested) against Leishma-
nia sp., are both involved in interactions with the sterols 
of fungal membranes that lead to cell death. The former 
cause death by inhibiting the demethylation of lanosterol 
and the latter disrupts the synthesis of ergosterol (Ghan-
noum & Rice 1999). The antileishmanial activities of 
these molecules is thus due to the relatively high content 
of ergosterol in the membranes of Leishmania and the 
result of similar mechanisms to those occurring in fungi 
(Gebre-Hiwot & Frommel 1993). In addition, miltefos-
ine interferes with phospholipid metabolism (Tong et al. 
2007). Targeting antifungal natural products potentially 
having an effect on Leishmania cell membrane is thus 
relevant (Bou et al. 2014). To our knowledge, this is the 
first time that such a correspondence in activity has been 
shown for EOs, even though the modes of actions should 
be investigated further.
At this stage of the study, the EOs found to exhibit both 
the best antifungal activity and the lowest IC50 against ax-
enic amastigotes were those of O. azureus, C. citratus, 
P. heptaphyllum and P. hispidum. The toxicities of these 
EOs towards BALB/c mice peritoneal macrophages were 
then also evaluated. The best selectivity indices regard-
ing antiparasitic activity were obtained for the O. azureus 
(71), P. heptaphyllum (19) and P. hispidum (11) EOs. These 
three EOs were also non-toxic to VERO cells, whereas 
the C. citratus EO had a TD50 of 30.7 µg/mL. It should 
be noted that the O. azureus and P. heptaphyllum EOs 
or extracts have never been described as antileishmanial 
agents. Though P. hispidum extracts are already known 
for their antileishmanial activity against L. amazonensis 
(Estevez et al. 2007, Ruiz et al. 2011), this is the first time 
that these properties are described for the EO.
To confirm the potential use of these EOs as antileish-
manial agents and corroborate the results indicating that 
the examination of alternative uses of natural antifungal 
products could lead to the discovery of promising anti- 
leishmanial drugs, we evaluated the activity of these last 
three oils on L. amazonensis-infected BALB/c mice peri-
toneal macrophages, excluding the C. citratus EO because 
of its relative toxicity. As Leishmania parasites survive 
and multiply within mammalian macrophages, this model 
produces results more closely related to in vivo results and 
a therapeutic drug can only demonstrate activity if it can 
cross the host cell membrane and act on the intracellular 
amastigotes (Kyriazis et al. 2013, Rodrigues et al. 2013). 
The EO of P. hispidum was clearly the most potent and 
promising oil, with an IC50 of 4.7 µg/mL and a safety index 
of 8, a value superior to the one calculated for the refer-
ence drug amphotericin B. This EO reduced the infection 
by 97.5% at 20 µg/mL. The present results confirm the 
interest of natural compounds study, including crude ex-
tracts or fractions, for the discovery of potent antileish- 
manial compounds, as underlined by Rabito et al. (2014).
The compositions of some P. hispidum EOs have al-
ready been described in the literature (Pino et al. 2004, 
Benitez et al. 2009, Cruz et al. 2012, Assis et al. 2013, 
Morales et al. 2013). Our findings are consistent with 
previous results; the P. hispidum EO extracted in this 
study was mainly composed of sesquiterpenes, though 
the proportions of oxygenated sesquiterpenes and ses-
quiterpene hydrocarbons are highly variable. This re-
sult possibly being due to seasonal or environmental 
variations (Figueiredo et al. 2008, Duarte et al. 2009), 
repeating this study on new P. hispidum collections and 
extractions could therefore help to assure the correla-
tion between the EO composition and biological activity. 
Curzerene has been previously identified in some oils, 
but never as the major component (Benitez et al. 2009). 
In our hands, the P. hispidum EO was shown to contain 
both curzerene and its precursor furanodiene and the 
relative proportion of curzerene calculated by GC analy-
sis was thus overestimated. Other furanosesquiterpenes 
were detected by GC/MS and NMR analysis but could 
not be identified. Curzerene has already been found in 
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other antileishmanial EOs (Rodrigues et al. 2013) and, 
considering our findings, furanosesquiterpenes could 
contribute to the antileishmanial activity of the P. his-
pidum EO. Moreover, β-caryophyllene, which accounts 
for 4.7% of this EO, is known to be an antileishmanial 
compound, possibly having an antileishmanial activity 
associated with the inhibition of the biosynthesis of cel-
lular isoprenoids (Santos et al. 2008). According to these 
data and those concerning the other active EOs, cor-
relating the chemical composition of the EOs and their 
biological activity, for example through a metabolomic 
approach, could lead to valuable information. Indeed, 
β-caryophyllene representing in particular only 0.52% 
of O. azureus EO (Houël et al. 2014) and not having been 
identified in P. heptaphyllum EO, other potent antileish-
manial molecules could thus be revealed.
In conclusion, the bioinspired selection of fragrant 
species successfully led to the identification of strongly 
antifungal compositions. This study also demonstrated 
the significant antileishmanial potential of the EO of P. 
hispidum against L. amazonensis, pending confirmation 
with in vivo assays. It would also be an interesting per-
spective to perform synergy studies between the most 
abundant compounds and antileishmanial chemothera-
peutics as amphotericin B, as well as further investigate 
the role of synergy concerning biological activity and se-
lectivity of the crude oil itself. Eventually, the evaluation 
of the antidermatophytic activities of EOs appears to be 
a promising strategy for the discovery of new natural an-
tileishmanial products, a significant achievement within 
the context of the alternative drug use, especially consid-
ering factors such as the low cost, high accessibility, high 
availability and reduced cytotoxicity of these products.
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